0001140361-21-019780.txt : 20210603
0001140361-21-019780.hdr.sgml : 20210603
20210603200106
ACCESSION NUMBER: 0001140361-21-019780
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210603
DATE AS OF CHANGE: 20210603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIMON IRWIN D
CENTRAL INDEX KEY: 0000922748
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38594
FILM NUMBER: 21994366
MAIL ADDRESS:
STREET 1: C/O THE HAIN CELESTIAL GROUP INC.
STREET 2: 1111 MARCUS AVENUE
CITY: LAKE SUCCESS
STATE: NY
ZIP: 11042
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tilray, Inc.
CENTRAL INDEX KEY: 0001731348
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 824310622
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 745 FIFTH AVENUE
STREET 2: SUITE 1602
CITY: NEW YORK
STATE: NY
ZIP: 10151
BUSINESS PHONE: 519.322.8800
MAIL ADDRESS:
STREET 1: 745 FIFTH AVENUE
STREET 2: SUITE 1602
CITY: NEW YORK
STATE: NY
ZIP: 10151
4
1
form4.xml
FORM 4
X0306
4
2021-06-01
0001731348
Tilray, Inc.
TLRY
0000922748
SIMON IRWIN D
C/O TILRAY, INC.
745 FIFTH AVENUE, SUITE 1602
NEW YORK
NY
10151
true
true
President and CEO
Class 2 Common Stock
2021-06-01
4
M
0
72683
A
285003
D
Class 2 Common Stock
2021-06-01
4
F
0
36248
16.98
D
248755
D
Class 2 Common Stock
2021-06-01
4
M
0
242277
A
491032
D
Class 2 Common Stock
2021-06-01
4
F
0
120824
16.98
D
370208
D
Restricted Stock Units
2021-06-01
4
M
0
72683
0
D
Class 2 Common Stock
72683
72693
D
Restricted Stock Units
2021-06-01
4
M
0
242277
0
D
Class 2 Common Stock
242277
242313
D
These shares were retained by Tilray, Inc. via settlement on a net withholding basis in order to meet the tax withholding obligations of the Reporting Person in connection with the vesting of an installment of restricted stock units granted to the Reporting Person on January 22, 2020.
Restricted stock units convert into shares of Class 2 Common Stock on a one-for-one basis.
On January 22, 2020, the reporting person was granted 218,038 restricted stock units, 33.33% of which vested on June 1, 2020; 33.33% of which vested on June 1, 2021; and the remaining 33.34% of which will vest on June 1, 2022.
On January 22, 2020, the reporting person was granted 726,794 restricted stock units, 33.33% of which vested on June 1, 2020; 33.33% of which vested on June 1, 2021; and the remaining 33.34% of which will vest on June 1, 2022.
/s/ Carl A. Merton, as Attorney-in-Fact for Irwin D. Simon
2021-06-03